Haloperidol (Akorn, Inc.)
Welcome to the PulseAid listing for the Haloperidol drug offered from Akorn, Inc.. This Typical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Akorn, Inc. |
| NON-PROPRIETARY NAME: | Haloperidol Lactate |
| SUBSTANCE NAME: | HALOPERIDOL LACTATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Typical Antipsychotic [EPC] |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-09-06 |
| END MARKETING DATE: | 0000-00-00 |
Haloperidol HUMAN PRESCRIPTION DRUG Details:
| Item Description | Haloperidol from Akorn, Inc. |
| LABELER NAME: | Akorn, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/mL) |
| START MARKETING DATE: | 2017-09-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 17478-110_04f6c8cd-5330-4d38-8318-0ea805e56034 |
| PRODUCT NDC: | 17478-110 |
| APPLICATION NUMBER: | ANDA204849 |
Other HALOPERIDOL LACTATE Pharmaceutical Manufacturers / Labelers:
